Philip Morris International Earnings Call Signals Smoke-Free Surge
Philip Morris International ((PM)) has held its Q4 earnings call. Read on for the main highlights of the call.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Philip Morris International Delivers Strong Smoke-Free Growth Amid Emerging Headwinds
Philip Morris International’s latest earnings call painted a picture of a company in the midst of a powerful transformation—operationally and financially. Management emphasized robust growth in smoke-free products, notable margin expansion, rising profitability and strong cash generation, with several strategic targets met ahead of schedule. At the same time, they openly flagged a cluster of near-term risks: tax-driven disruption in Japan and key emerging markets, U.S. regulatory uncertainty, currency volatility in Q4, and some inventory and supply constraints. The overall tone was confident and upbeat about the multi-year outlook, but pragmatic about execution and regulatory hurdles that could cause bumps along the way.
Smoke-Free Volume Growth Powers the Transition
Smoke-free products remain the core growth engine for PMI. Shipments of smoke-free units rose 12.8% year-over-year, adding roughly 20 billion units to reach about 179 billion units in 2025. IQOS, the flagship heated-tobacco platform, grew shipments by around 11%, to approximately 155 billion units. Adjusted in-market sales accelerated late in the year, with IQOS IMS up about 12% in the fourth quarter and 10.5% for the full year, underscoring both strong consumer adoption and growing category penetration. This momentum is critical as PMI aims to pivot away from traditional cigarettes and build a higher-margin, regulatory-resilient portfolio.
Profitability and Margins Reach New Highs
PMI coupled its volume story with impressive profitability gains. Adjusted operating income climbed 11.8% in dollar terms to $16.4 billion, with organic operating income up 10.6%. Organic operating margins expanded by 140 basis points, lifting the adjusted operating income margin to 40.4%. Gross margin improved even more sharply, expanding organically by about 220 basis points to above 67%. Smoke-free products were at the forefront of this margin story, with smoke-free adjusted gross margin increasing roughly 270 basis points to about 69.5%. This mix and efficiency improvement illustrates that PMI’s shift toward smoke-free is not just about volume, but also about structurally better economics.
Record Revenue Mix Shift Toward Smoke-Free
The revenue profile of the group is being reshaped at speed. Total net revenues exceeded $40 billion in 2025, with smoke-free products now contributing about 41.5% of the total—around $17 billion. Over the past five years, smoke-free’s gross contribution has doubled to roughly 43% of PMI’s overall gross profit. This marks a key milestone in the company’s strategic ambition to become a predominantly smoke-free business, reducing exposure to declining combustible volumes and traditional cigarette regulation, while building a platform for more durable growth.
EPS Upside and Strong Cash Generation Support Deleveraging
Earnings and cash flow provided further support for PMI’s investment case. Adjusted diluted EPS rose about 15% in dollar terms (14.2% on a currency-neutral basis) to $7.54, landing at the high end of guidance. Operating cash flow remained robust at $12.2 billion, matching the prior year. Management also outlined a path to accelerate cash generation to around €13.5 billion at prevailing rates and to reduce net leverage from 2.5x at the end of 2025 to close to 2x by the end of 2026. This combination of earnings growth, cash generation and deleveraging gives PMI financial flexibility to sustain dividends and fund further investment in smoke-free categories.
ZYN and Multi-Category Strategy Gain Traction
Beyond heated tobacco, PMI highlighted strong execution in oral nicotine and e-vapor. ZYN shipments increased roughly 36–37% globally, as the brand expanded into about 56 markets, adding 19 new markets during the year. ZYN now holds around 40% of PMI’s pouch-category share and continues to post significant share gains in the U.S., where it leads the premium segment. U.S. shipments grew despite supply constraints, underlining robust underlying demand. Meanwhile, e-vapor brand VIVE doubled its shipments over the year and improved profitability, with a footprint in about 47 markets. This multi-category approach is intended to diversify growth, reduce reliance on any single format and strengthen PMI’s competitive positioning across the reduced-risk spectrum.
Geographic Milestones Underscore the Scale of the Transformation
PMI’s smoke-free strategy is increasingly global in scope. The company now offers smoke-free products in 106 markets, with 52 of those already deploying a full category strategy. Twenty-seven markets generated more than half of their net revenue from smoke-free products, and eight markets— including the U.S.—exceeded 75% smoke-free net revenue. Europe as a region surpassed 50% smoke-free net revenue for the year, marking a significant regional turning point. PMI estimates that the number of legal-age users of its smoke-free products has reached around 43.5 million, up roughly 10 million in just two years, underscoring the pace at which smokers are being converted to alternative products.
Strategic Targets Delivered Early and New Medium-Term Goals Set
Management emphasized that PMI has already achieved its three-year compound annual growth rate (CAGR) targets for organic operating income and currency-neutral EPS in only two years. Riding on this execution, the company renewed and extended its medium-term guidance for 2026–2028: organic net revenue growth of 6–8% per year, organic operating income growth of 8–10%, and constant-currency adjusted diluted EPS growth of 9–11%. For 2026 specifically, PMI is targeting organic net revenue growth of 5–7%, organic operating income growth of 7–9%, and currency-neutral EPS growth of 7.5–9.5%, translating into $8.09–$8.54 including a favorable currency effect. These targets indicate that management sees the smoke-free transition as a long runway rather than a short-lived phase.
Cost Savings and Efficiency Drive Further Upside
Cost discipline and efficiency initiatives are providing additional leverage to earnings. PMI has delivered around $1.5 billion of growth-related cost savings since 2024 and remains on track to reach a $2 billion savings objective over 2024–2026. Management also pointed to further expected efficiency gains, including productivity enhancements from AI and digital tools. These savings are helping to fund increased commercial investment in growth areas while still delivering margin expansion—an important buffer against regulatory, tax, and competitive pressures.
Japan Excise Changes Set Up an Atypical 2026
One of the most notable risks flagged was Japan’s planned excise tax increases on heated tobacco, scheduled in two steps during 2026. These changes are expected to create a transitory headwind for both the category and IQOS, potentially dampening in-market growth and driving shipment volatility during the year. Management called out 2026 as an “atypical” year for Japan, with meaningful implications for volumes and pricing dynamics, even though they remain confident in the long-term prospects of heated tobacco in the market.
Combustible Decline and Regional Excise Pressure
As PMI pushes toward smoke-free, its combustible cigarette business continues to decline in a managed fashion. Cigarette shipments fell 1.5% in 2025, slightly better than earlier expectations, but the company forecasts about a 3% decline in combustibles for 2026. This trend is being amplified in some markets by sharp excise-driven price increases. India, for example, saw consumer prices jump by more than 40%, and Mexico also faces significant tax-related price hikes. Such moves are expected to weigh on industry volumes and create tougher year-on-year comparisons, even as they reinforce the strategic rationale for shifting consumers to smoke-free alternatives.
U.S. ZYN: Supply, Inventory and Regulatory Uncertainty
The U.S. remains a major growth opportunity for ZYN but also a source of complexity. In the first half of 2025, ZYN faced supply constraints that limited availability even as demand remained strong. U.S. shipments still rose about 37%, while Nielsen-measured offtake increased roughly 25%, indicating a rebuilding of channel inventories. PMI estimates that around 25 million cans of surplus downstream inventory now need to normalize, which could distort near-term shipment trends. Looking ahead, growth depends heavily on the timing and outcome of U.S. regulatory decisions, including pending product submissions such as ZYN Ultra. These regulatory milestones could either unlock further growth or delay key innovations, introducing execution and timing risk.
Currency Volatility and Q4 Transactional Losses
Despite strong underlying performance, Q4 results were partially tempered by currency effects. Transactional losses linked mainly to movements in the Russian ruble and Swiss franc reduced the expected currency tailwind by about four cents per share. While management framed these as one-off impacts, they did dilute some of the dollar-denominated EPS upside versus prior expectations. The episode underlines the reality that, for a globally diversified company like PMI, foreign exchange remains an unavoidable source of earnings volatility.
Competitive Intensity, Supply Chain Issues and Promotional Normalization
Management also flagged several operational and competitive challenges across markets. In Japan and other key geographies, competitive activity has intensified, which can affect short-term category growth and market share even as IQOS remains resilient. In Turkey, supply-chain disruptions weighed on combustible performance and are expected to influence first-half 2026 comparisons as the recovery continues. In the U.S., promotional activity normalized in the second half following earlier variances, creating mix and phasing effects. PMI plans to increase commercial investment in 2026 after a year of relatively low promotional intensity, which could pressure near-term margins but is aimed at sustaining category growth.
Regulatory and Tax Overhang in the U.S. States
Beyond federal regulation, PMI faces an evolving patchwork of state-level tax and regulatory risk in the United States. Management highlighted potential subnational excise proposals, such as higher taxes on nicotine pouches in certain states, which could change category economics and promotional strategies. These developments, together with broader regulatory uncertainty, may affect competitive dynamics in the pouch category and add another layer of risk for investors to monitor, particularly as ZYN becomes a larger contributor to PMI’s growth.
Guidance: Strong 2026 Outlook With a Soft Start
Looking ahead, PMI guided to another year of solid growth in 2026, despite acknowledging Japan excise changes and U.S. ZYN inventory normalization as key headwinds. The company expects organic net revenue to increase by 5–7% and organic operating income by 7–9%. Currency‑neutral adjusted diluted EPS is forecast to rise 7.5–9.5%, implying a dollar EPS range of $8.09–$8.54 when including a projected currency benefit—equating to about 11.3–13.3% growth in dollar terms. Smoke‑free shipments and adjusted IMS are expected to grow in the high‑single‑digit range, while combustible cigarette shipments are seen declining around 3%, leaving total volumes broadly stable. Management flagged the first quarter as the softest of the year, with combustible volumes potentially down up to 5% and revenue and operating income roughly flat, and guided Q1 adjusted EPS to $1.80–$1.85 including a favorable FX impact. Operating cash flow is projected to accelerate to approximately €13.5 billion, with an effective tax rate near 21.5%, stable net finance costs, leverage targeted close to 2.0x by year-end 2026, and a dividend payout ratio maintained around 75% of adjusted EPS. PMI also reaffirmed its 2026–2028 CAGRs of 6–8% for organic net revenue, 8–10% for organic operating income, and 9–11% for constant-currency adjusted EPS, with smoke-free growth targeted in the high-single-digits to low-teens.
In summary, Philip Morris International’s earnings call showcased a company executing strongly on a structural shift toward higher-margin, smoke-free products, with robust growth, expanding margins, and healthy cash generation. Management is delivering on strategic promises ahead of schedule and laying out ambitious yet credible medium-term targets. At the same time, investors will need to navigate a complex near-term landscape shaped by excise hikes in Japan and emerging markets, U.S. regulatory and tax uncertainty, competitive intensity, and FX volatility. For long-term investors, PMI’s story remains one of transformation and cash-backed growth, but one that will likely feature periods of volatility as regulatory and market dynamics play out.
